antipsychotic

MILAN, Italy and MORRISTOWN, N.J., September 2, 2026 Newron Pharmaceuticals S.p.A. announced completion of screening for enrollment in its...

New York, USA | March 27, 2026 LB Pharmaceuticals announced new findings from its Phase 2 NOVA-1 clinical trial,...